GlassScriptPhysician profile
Nathan P Douglass
NPI 1407147655
$2,421.72
in general payments reported to CMS, 2019-2025
9 companies · $316 in 2025
The $316 reported for 2025 was more than what a typical Hand Surgery provider received nationally (typical 2025 total: $270).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $68.69 · 2020: $876 · 2021: $531 · 2022: $413 · 2023: $87.21 · 2024: $129 · 2025: $316.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $533.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $532.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,237.63 | 2020-2025 | Axsos, Mako, Variax |
| Gotham Surgical Solutions & Devices, INC. | $716.00 | 2020 | |
| Bioventus LLC | $126.26 | 2023-2024 | Exogen Ultrasound Bone Healing System, Durolane, Exogen Ultrasound Bone Healing System |
| Arthrex, INC. | $125.00 | 2021 | |
| Exsomed Corporation | $78.00 | 2020 | |
| Endo Pharmaceuticals INC. | $66.80 | 2019-2020 | |
| Endo USA, INC. | $40.44 | 2025 | Xiaflex |
| Checkpoint Surgical, INC | $18.21 | 2022 | |
| Sanofi-Aventis U.S. LLC | $13.38 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nathan Douglass listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.